2026 Q3 Portfolio Activity
In 2026 Q3, Elmind Capital, LP maintained a portfolio of 35 distinct positions. They heavily accumulated shares in AMYLYX PHARMACEUTICALS INC, increasing the position by 698.9%. The fund also reduced its exposure to COGENT BIOSCIENCES INC by 26.0%.
Position History
hover any row below to update
Loading…
Total Positions
35
Quarter
2026 Q3
Top Holding
CLDX (8.9%)
Top 10 Concentration
65.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-35 of 35
Elmind Capital, LP Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 8.91% | 9.25% |
#1
2
Prev: #3
|
7.6 |
—
|
120,000 | 12.1% |
P
S
|
1,110,000 | $35,975,100 |
$28.86
-2.9%
|
2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
LEGN
LEGEND BIOTECH ...
|
Healthcare | 7.73% | 4.14% |
#2
9
Prev: #11
|
7.6 |
—
|
999,107 | 175.1% |
P
S
|
1,569,676 | $31,220,856 |
$23.16
-30.4%
|
2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 7.47% | 10.19% |
#3
1
Prev: #2
|
4.5 |
—
|
-250,000 | -13.5% |
P
S
|
1,605,000 | $30,174,000 |
$21.01
-56.2%
|
2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 6.87% | 11.38% |
#4
3
Prev: #1
|
3.2 |
—
|
-303,998 | -26.0% |
P
S
|
866,742 | $27,753,079 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 6.55% | 6.89% |
#5
1
Prev: #4
|
4.1 |
—
|
no change | no change |
P
S
|
1,465,279 | $26,448,286 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 6.45% | 0.51% |
#6
22
Prev: #28
|
5.6 |
—
|
782,760 | 698.9% |
P
S
|
894,760 | $26,037,516 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 6.25% | 4.55% |
#7
1
Prev: #8
|
5.0 |
—
|
240,000 | 24.4% |
P
S
|
1,224,931 | $25,221,329 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 5.25% | 6.61% |
#8
3
Prev: #5
|
2.6 |
—
|
-80,000 | -17.7% |
P
S
|
372,340 | $21,186,146 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
URGN
UROGEN PHARMA L...
|
Healthcare | 4.94% | 1.11% |
#9
13
Prev: #22
|
5.0 |
—
|
371,100 | 309.2% |
P
S
|
491,100 | $19,953,393 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 4.70% | 4.18% |
#10
Prev: #10
|
3.9 |
—
|
30,000 | 10.3% |
P
S
|
322,600 | $18,994,688 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CGEM
CULLINAN THERAP...
|
Healthcare | 3.66% | 3.16% |
#11
2
Prev: #13
|
4.0 |
—
|
272,792 | 39.5% |
P
S
|
962,792 | $14,778,857 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 3.58% | 4.57% |
#12
5
Prev: #7
|
1.9 |
—
|
-70,000 | -13.3% |
P
S
|
455,750 | $14,456,390 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 3.49% | 4.71% |
#13
7
Prev: #6
|
2.4 |
—
|
no change | no change |
P
S
|
436,518 | $14,095,166 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 3.06% | 4.29% |
#14
5
Prev: #9
|
2.2 |
—
|
no change | no change |
P
S
|
4,550,000 | $12,376,000 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BEAM
BEAM THERAPEUTI...
|
Healthcare | 2.88% | 4.11% |
#15
3
Prev: #12
|
2.2 |
—
|
no change | no change |
P
S
|
476,338 | $11,646,464 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 2.70% | 2.80% |
#16
2
Prev: #14
|
2.1 |
—
|
no change | no change |
P
S
|
460,000 | $10,906,600 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SMMT
SUMMIT THERAPEU...
|
Healthcare | 2.07% | 1.81% |
#17
Prev: #17
|
1.8 |
—
|
no change | no change |
P
S
|
493,820 | $8,350,496 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 2.01% | 2.04% |
#18
2
Prev: #16
|
1.8 |
—
|
no change | no change |
P
S
|
15,000 | $8,128,350 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 1.92% | 0.65% |
#19
8
Prev: #27
|
3.8 |
—
|
175,000 | 215.7% |
P
S
|
256,143 | $7,758,571 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 1.81% | 2.05% |
#20
5
Prev: #15
|
1.7 |
—
|
no change | no change |
P
S
|
22,000 | $7,316,320 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ALMS
ALUMIS INC
|
Healthcare | 1.37% | 0.92% |
#21
3
Prev: #24
|
3.5 |
—
|
619,560 | 476.6% |
P
S
|
749,560 | $5,539,248 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BCRX
BIOCRYST PHARMA...
|
Healthcare | 1.07% | 1.31% |
#22
3
Prev: #19
|
1.4 |
—
|
no change | no change |
P
S
|
520,000 | $4,331,600 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
STRO
SUTRO BIOPHARMA...
|
Healthcare | 0.91% | 0.27% |
#23
9
Prev: #32
|
3.4 |
—
|
196,228 | 612.5% |
P
S
|
228,265 | $3,677,349 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 0.89% | 1.26% |
#24
4
Prev: #20
|
0.4 |
—
|
-30,000 | -33.0% |
P
S
|
61,000 | $3,575,820 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DBVT
DBV TECHNOLOGIE...
|
Healthcare | 0.77% | 1.09% |
#25
2
Prev: #23
|
1.3 |
—
|
no change | no change |
P
S
|
265,000 | $3,116,400 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SUPN
SUPERNUS PHARMA...
|
Healthcare | 0.75% | 0.82% |
#26
1
Prev: #25
|
1.3 |
—
|
no change | no change |
P
S
|
70,000 | $3,012,800 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 0.70% | 0.68% |
#27
1
Prev: #26
|
1.3 |
—
|
no change | no change |
P
S
|
47,000 | $2,820,000 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SEPN
SEPTERNA INC
|
Healthcare | 0.48% | 0.42% |
#28
2
Prev: #30
|
1.2 |
—
|
no change | no change |
P
S
|
49,444 | $1,934,744 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ALEC
ALECTOR INC
|
Healthcare | 0.42% | 0.45% |
#29
Prev: #29
|
0.7 |
—
|
15,902 | 1.8% |
P
S
|
915,902 | $1,694,419 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DSGN
DESIGN THERAPEU...
|
Healthcare | 0.34% | 0.39% |
#30
1
Prev: #31
|
1.1 |
—
|
no change | no change |
P
S
|
107,900 | $1,356,303 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ENGN
ENGENE THERAPEU...
|
Healthcare | 0.00% | 0.09% |
Sold All 😨
(Was: #35) |
0.0 |
—
|
-210,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TYRA
TYRA BIOSCIENCE...
|
Healthcare | 0.00% | 0.16% |
Sold All 😨
(Was: #34) |
0.0 |
—
|
-20,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
WVE
WAVE LIFE SCIEN...
|
Healthcare | 0.00% | 0.26% |
Sold All 😨
(Was: #33) |
0.0 |
—
|
-177,846 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 0.00% | 1.17% |
Sold All 😨
(Was: #21) |
0.0 |
—
|
-38,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
INSM
INSMED INC
|
Healthcare | 0.00% | 1.74% |
Sold All 😨
(Was: #18) |
0.0 |
—
|
-65,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-35 of 35 holdings